Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market 2019 | Industry Analysis by Share, Size, Competitive Strategies, Boosting Business Plans Forecast to 2024

Sodium-dependent

TheSodium-dependent Glucose Co-transporter 2 (SGLT 2) Marketresearch report 2019-2024 focuses on provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data. Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market report also provides the current industry outlook with respect to key players, types, applications, countries and regions. The major drivers, restraints, opportunities and threats for key players is also included. It also provides granular analysis of market share, segmentation, revenue forecasts and regional analysis till 2024.

Market Overview:

  • The SGLT2 inhibitors class of drugs include Jardiance, Fraxiga, Inovokana, and Suglat, among others. The demand for SGLT2 is expected to grow immensely, due to drugs like Jardiance and Farxiga.
  • The growing global type-2 diabetes population promotes the growth of SGLT2 drugs. The global SGLT2 market has a high potential for growth, due to the increasing number of diabetic patients and their need for drugs that help reduce high blood glucose levels, despite being on a medication regimen, such as metformin and insulin. SGLT2 serves this specific purpose.
  • The global market for SGLT2 is worth USD 6,573.8 million in 2019 and is expected to grow at CAGR of 16% by 2024.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999739

    Scope of the Report:

  • The report includes a complete study of SGLT2 inhibitors, which include Invokana, Jardiance, Farxiga, and Suglat. The study is further divided into regional- and country-wise analyses, which cover all the drugs in the SGLT2 class.

    List of Key Manufacturers Covered in Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market:

  • Eli Lilly
  • Janssen Pharmaceuticals
  • Astellas
  • Boehringer Ingelheim
  • AstraZeneca
  • Bristol Myers Squibb

    Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market Report Covers the Following: –

    • The report covers forecast and analysis for the market on a global and regional level.
    • The report includes the drivers and the restraints that affect the growth of the market.
    • The report discusses detailed information about the market opportunities.
    • The market is segmented on the basis of product and end-user industry
    • The key target audience for the market has been determined in the report.
    • The revenue generated by the prominent industry players has been analyzed in the report.

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999739

    Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market Report Highlights:

    • Comprehensive pricing analysis on the basis of product, application, and regional segments
    • The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market
    • Deep insights about regulatory and investment scenarios of the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market
    • Analysis of market effect factors and their impact on the forecast and outlook of the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market
    • A roadmap of growth opportunities available in the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market with the identification of key factors
    • The exhaustive analysis of various trends of the Sodium-dependent Glucose Co-transporter 2 (SGLT 2) market to help identify market developments

    Key Market Trends: – Jardiance is Leading the SGLT2 Market.

    Jardiance, which was released globally in 2014, is a once-daily oral medication that is used to control blood glucose levels in people with type-2 diabetes.
    Jardince is gaining sales when compared to Invokana, with patients preferring this drug, as it has a lower risk of cardiovascular diseases when compared to other SGLT2 drugs, by helping the kidneys remove glucose from the bloodstream.
    Jardiance accounted for 41.5% of the sales in the global SGLT2 class of drugs in 2017. The market for Jardince was worth USD 2.5 billion in 2018 and is expected to grow at a CAGR of 15.78%, during the forecast period (2019-2024).

    65% of the Market Share is Occupied by North America.
    The growing global type-2 diabetes population promotes the growth of SGLT2 drugs. North America accounts for the highest type- 2 diabetic population. Prices are comparatively high in this region.
    The North America SGLT2 market accounts for USD 3,471.5 million in 2018 and is expected to grow at CAGR of 15.5% by 2024.
    In the United States, there are close to 900 lawsuits currently pending, regarding Invokana. Jardiance holds 50% of the market share in the US SGLT2 market.

    Purchase this Report (Price 5000 USD for single user license) – https://www.industryresearch.co/purchase/13999739

    Detailed TOC of Sodium-dependent Glucose Co-transporter 2 (SGLT 2) Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug
    5.1.1 Sodium – Glucose Cotransport -2 (SGLT-2) Inhibitor (Value and Volume 2012-2024)
    5.1.1.1 Invokana (Canagliflozin)
    5.1.1.2 Jardiance (Empagliflozin)
    5.1.1.3 Farxiga/Forxiga (Dapagliflozin)
    5.1.1.4 Suglat (Ipragliflozin)
    5.2 Geography
    5.2.1 North America
    5.2.1.1 United States (Value and Volume 2012-2024)
    5.2.1.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.2 Canada (Value and Volume 2012-2024)
    5.2.1.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.1.3 Rest of North America (Value and Volume 2012-2024)
    5.2.1.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2 Europe
    5.2.2.1 France (Value and Volume 2012-2024)
    5.2.2.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.2 Germany (Value and Volume 2012-2024)
    5.2.2.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.3 Italy (Value and Volume 2012-2024)
    5.2.2.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.4 Spain (Value and Volume 2012-2024)
    5.2.2.4.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.5 UK (Value and Volume 2012-2024)
    5.2.2.5.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.6 Russia (Value and Volume 2012-2024)
    5.2.2.6.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.2.7 Rest of Europe (Value and Volume 2012-2024)
    5.2.2.7.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.3 Latin America
    5.2.3.1 Mexico (Value and Volume 2012-2024)
    5.2.3.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.3.2 Brazil (Value and Volume 2012-2024)
    5.2.3.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.3.3 Rest of Latin America (Value and Volume 2012-2024)
    5.2.3.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4 Asia-Pacific
    5.2.4.1 Japan (Value and Volume 2012-2024)
    5.2.4.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.2 South Korea (Value and Volume 2012-2024)
    5.2.4.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.3 China (Value and Volume 2012-2024)
    5.2.4.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.4 India (Value and Volume 2012-2024)
    5.2.4.4.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.5 Australia (Value and Volume 2012-2024)
    5.2.4.5.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.6 Vietnam (Value and Volume 2012-2024)
    5.2.4.6.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.7 Malaysia (Value and Volume 2012-2024)
    5.2.4.7.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.8 Indonesia (Value and Volume 2012-2024)
    5.2.4.8.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.9 Philippines (Value and Volume 2012-2024)
    5.2.4.9.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.10 Thailand (Value and Volume 2012-2024)
    5.2.4.10.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.4.11 Rest of Asia-Pacific (Value and Volume 2012-2024)
    5.2.4.11.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5 Middle East & Africa
    5.2.5.1 Saudi Arabia (Value and Volume 2012-2024)
    5.2.5.1.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5.2 Iran (Value and Volume 2012-2024)
    5.2.5.2.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5.3 Egypt (Value and Volume 2012-2024)
    5.2.5.3.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5.4 Oman (Value and Volume 2012-2024)
    5.2.5.4.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5.5 South Africa (Value and Volume 2012-2024)
    5.2.5.5.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)
    5.2.5.6 Rest of Middle & Africa (Value and Volume 2012-2024)
    5.2.5.6.1 By Drug (Invokana, Jardiance, Farxiga, Suglat)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Eli Lilly
    7.1.2 Janssen Pharmaceuticals
    7.1.3 Astellas
    7.1.4 Boehringer Ingelheim
    7.1.5 AstraZeneca
    7.1.6 Bristol Myers Squibb
    7.2 MARKET SHARE ANALYSIS
    7.2.1 Eli Lilly
    7.2.2 Janssen Pharmaceuticals
    7.2.3 Astellas
    7.2.4 Boehringer Ingelheim
    7.2.5 AstraZeneca

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Fuel Dispenser Market Growth Opportunities 2019 by Size, Driving Factors by Manufacturers, Regions, Type and Application, Revenue Market Forecast 2024

    Global Plant Squalane Market Share, Size 2019 Movements by Trend Analysis, Progression Status, Revenue Expectation to 2024 | Research Report by Industry Research.Biz

    Dentifrices Market Insights 2019 | Global Size Analysis, Top Countries Data, Industry Trends, Revenue Forecast to 2024

    Global Business Jet Market Analysis and Forecast to 2025 by Recent Trends, Developments in Manufacturing Technology and Regional Growth Overview

    Global Waste Paper Recycling Market Share, Size 2019 – Industry Future Demand, Worldwide Research, Top Leading Players, Emerging Trends, Region by Forecast to 2024

  • Avatar

    sambit